Cargando…
Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab
Hepatitis B virus (HBV) reactivation in the setting of rituximab use is a potentially fatal but preventable safety event. The rate of HBV screening and proportion of patients at risk who receive antiviral prophylaxis in patients initiating rituximab is unknown. We analyzed electronic health record (...
Autores principales: | Schmajuk, Gabriela, Tonner, Chris, Trupin, Laura, Li, Jing, Sarkar, Urmimala, Ludwig, Dana, Shiboski, Stephen, Sirota, Marina, Dudley, R. Adams, Murray, Sara, Yazdany, Jinoos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380298/ https://www.ncbi.nlm.nih.gov/pubmed/28353614 http://dx.doi.org/10.1097/MD.0000000000006528 |
Ejemplares similares
-
Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data
por: Gianfrancesco, Milena A., et al.
Publicado: (2019) -
Prophylaxis of ibuprofen in acute mountain sickness: A protocol for systematic review and meta-analysis
por: Yi, Hai, et al.
Publicado: (2020) -
Knowledge, attitudes, and practices regarding venous thromboembolism prophylaxis: A survey of medical staff at a tertiary hospital in China
por: Feng, Shangpeng, et al.
Publicado: (2021) -
Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease: A Meta-Analysis
por: Shi, Yujie, et al.
Publicado: (2015) -
Is frailty a relevant concept in SLE?
por: Katz, Patricia P, et al.
Publicado: (2017)